Your email has been successfully added to our mailing list.

×
-0.00386100386100395 -0.00386100386100395 -0.0154440154440155 -0.0193050193050194 0.0135135135135134 0.0656370656370656 0.242741312741313 0.181467181467181
Stock impact report

Hemp's Resurgence Continues as the FDA Hones in on CBD

Tilray Brands, Inc. (TLRY) 
Last tilray brands, inc. earnings: 3/2 04:05 pm Check Earnings Report
Company Research Source: PR Newswire
NEW YORK, March 19, 2020 /PRNewswire/ -- CBD has garnered a strong reputation for its wide range of potential health benefits. However, it has only been approved to treat childhood epilepsy syndromes, such as Dravet syndrome and Lennox-Gastaut syndrome after the U.S. Food and Drug Administration approved Epidiolex, making it the first approved cannabis-based drug, last year. The FDA has made clear that additional research is required in order to advance with more approvals. The Administration has also held numerous public hearings in recent years in order to further understand the efficacy of CBD. And while only one cannabis-based drug has been approved, the efforts of the FDA indicate that CBD is gathering a strong momentum as a possible medical substance. "As legislation expands rapidly worldwide, the volume of efficacy data is growing, as are legitimate clinical trial studies," says Liam McGreevy, Chief Executive Officer of Ethnopharm, a European cannabis company specializing in ge Show less Read more
Impact Snapshot
Event Time:
TLRY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for TLRY alerts
Opt-in for
TLRY alerts

from News Quantified
Opt-in for
TLRY alerts

from News Quantified